Literature DB >> 22933353

Potential role of Demodex mites and bacteria in the induction of rosacea.

Stanisław Jarmuda1, Niamh O'Reilly2, Ryszard Żaba1, Oliwia Jakubowicz1, Andrzej Szkaradkiewicz3, Kevin Kavanagh2.   

Abstract

Rosacea is a common dermatological condition that predominantly affects the central regions of the face. Rosacea affects up to 3 % of the world's population and a number of subtypes are recognized. Rosacea can be treated with a variety of antibiotics (e.g. tetracycline or metronidazole) yet no role for bacteria or microbes in its aetiology has been conclusively established. The density of Demodex mites in the skin of rosacea patients is higher than in controls, suggesting a possible role for these mites in the induction of this condition. In addition, Bacillus oleronius, known to be sensitive to the antibiotics used to treat rosacea, has been isolated from a Demodex mite from a patient with papulopustular rosacea and a potential role for this bacterium in the induction of rosacea has been proposed. Staphylococcus epidermidis has been isolated predominantly from the pustules of rosacea patients but not from unaffected skin and may be transported around the face by Demodex mites. These findings raise the possibility that rosacea is fundamentally a bacterial disease resulting from the over-proliferation of Demodex mites living in skin damaged as a result of adverse weathering, age or the production of sebum with an altered fatty acid content. This review surveys the literature relating to the role of Demodex mites and their associated bacteria in the induction and persistence of rosacea and highlights possible therapeutic options.

Entities:  

Mesh:

Year:  2012        PMID: 22933353     DOI: 10.1099/jmm.0.048090-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  32 in total

1.  Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea.

Authors:  Lisa A Raedler
Journal:  Am Health Drug Benefits       Date:  2015-03

2.  Association study of Demodex bacteria and facial dermatoses based on DGGE technique.

Authors:  YaE Zhao; Fan Yang; RuiLing Wang; DongLing Niu; Xin Mu; Rui Yang; Li Hu
Journal:  Parasitol Res       Date:  2017-01-06       Impact factor: 2.289

3.  Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins.

Authors:  Fred McMahon; Nessa Banville; David A Bergin; Christian Smedman; Staffan Paulie; Emer Reeves; Kevin Kavanagh
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 4.  Skin barrier in rosacea.

Authors:  Flavia Alvim Sant'Anna Addor
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

5.  Topical application of a cleanser containing extracts of Diospyros kaki folium, Polygonum cuspidatum and Castanea crenata var. dulcis reduces skin oil content and pore size in human skin.

Authors:  Bo Mi Lee; Sungkwan An; Soo-Yeon Kim; Hyun Joo Han; Yu-Jin Jeong; Kyoung-Rok Lee; Nam Kyung Roh; Kyu Joong Ahn; In-Sook An; Hwa Jun Cha
Journal:  Biomed Rep       Date:  2015-02-25

6.  Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life.

Authors:  Tu T Huynh
Journal:  Am Health Drug Benefits       Date:  2013-07

Review 7.  Structure and function of the human skin microbiome.

Authors:  Nina N Schommer; Richard L Gallo
Journal:  Trends Microbiol       Date:  2013-11-12       Impact factor: 17.079

Review 8.  Antimicrobial peptides and wound healing: biological and therapeutic considerations.

Authors:  Maria Luisa Mangoni; Alison M McDermott; Michael Zasloff
Journal:  Exp Dermatol       Date:  2016-02-10       Impact factor: 3.960

9.  Ocular Demodex folliculorum: prevalence and associated symptoms in an Irish population.

Authors:  Orla Murphy; Veronica O'Dwyer; Aoife Lloyd-McKernan
Journal:  Int Ophthalmol       Date:  2018-01-29       Impact factor: 2.031

Review 10.  Functions of the skin microbiota in health and disease.

Authors:  James A Sanford; Richard L Gallo
Journal:  Semin Immunol       Date:  2013-11-20       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.